Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line
出版年份 2016 全文链接
标题
Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line
作者
关键词
Hepatocellular carcinoma, Liver cancer stem cells, microRNA-21, Cancer stem cell, Retroviral vector
出版物
World Journal of Surgical Oncology
Volume 14, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-10-28
DOI
10.1186/s12957-016-1028-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib
- (2015) Takeshi Yamada et al. BMC CANCER
- Emergence of cancer stem cells in hepatocellular carcinoma
- (2015) S. Pilz et al. EMBO JOURNAL
- Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches
- (2015) Tim F Greten et al. GUT
- Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling
- (2015) Xin Yin et al. Journal of Hematology & Oncology
- Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer
- (2015) Yue Zhao et al. Targeted Oncology
- Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma
- (2014) Hidenari Hirata et al. ANNALS OF SURGICAL ONCOLOGY
- Comparison of Survival of Patients with BCLC Stage A Hepatocellular Carcinoma After Hepatic Resection or Transarterial Chemoembolization: A Propensity Score-Based Analysis
- (2014) Zhe Guo et al. ANNALS OF SURGICAL ONCOLOGY
- A microRNA-operated switch of asymmetric-to-symmetric cancer stem cell divisions
- (2014) Robin G. Lerner et al. NATURE CELL BIOLOGY
- Inhibition of the Cancer Stem Cells-Like Properties by Arsenic Trioxide, Involved in the Attenuation of Endogenous Transforming Growth Factor Beta Signal
- (2014) Yuan Li et al. TOXICOLOGICAL SCIENCES
- Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma
- (2014) Zhe Guo WORLD JOURNAL OF GASTROENTEROLOGY
- Molecular Biology of Liver Cancer Stem Cells
- (2014) Naoki Oishi et al. Liver Cancer
- MicroRNAs in Cancer
- (2013) Gianpiero Di Leva et al. Annual Review of Pathology-Mechanisms of Disease
- OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma
- (2013) Lu Cao et al. BMC CANCER
- MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways
- (2013) Longlong Bao et al. CANCER LETTERS
- Cancer stem cells in the development of liver cancer
- (2013) Taro Yamashita et al. JOURNAL OF CLINICAL INVESTIGATION
- Recurrence of Hepatocellular Carcinoma in Noncirrhotic Liver After Hepatectomy
- (2013) Laurence Chiche et al. WORLD JOURNAL OF SURGERY
- MicroRNA-21 regulates stemness in cancer cells
- (2013) Hong-Yo Kang Stem Cell Research & Therapy
- Coexpression of Stemness Factors Oct4 and Nanog Predict Liver Resection
- (2012) Xin Yin et al. ANNALS OF SURGICAL ONCOLOGY
- Distinct Lineage Specification Roles for NANOG, OCT4, and SOX2 in Human Embryonic Stem Cells
- (2012) Zheng Wang et al. Cell Stem Cell
- Targeting CSC-Related miRNAs for Cancer Therapy by Natural Agents
- (2012) Bin Bao et al. CURRENT DRUG TARGETS
- Stemness as a cell default state
- (2012) Jordi Casanova EMBO REPORTS
- Discrete nature of EpCAM+and CD90+cancer stem cells in human hepatocellular carcinoma
- (2012) Taro Yamashita et al. HEPATOLOGY
- Resolving the stem-cell debate
- (2012) Richard J. Gilbertson et al. NATURE
- Increased CD13 Expression Reduces Reactive Oxygen Species, Promoting Survival of Liver Cancer Stem Cells via an Epithelial–Mesenchymal Transition-like Phenomenon
- (2011) Ho Min Kim et al. ANNALS OF SURGICAL ONCOLOGY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGF R2) in colon cancer cells
- (2011) Y. Yu et al. CARCINOGENESIS
- CD13: Waving the flag for a novel cancer stem cell target
- (2011) Bruno Christ et al. HEPATOLOGY
- Stem cells in liver diseases and cancer: Recent advances on the path to new therapies
- (2011) C. Bart Rountree et al. HEPATOLOGY
- Functional analysis of microRNAs in human hepatocellular cancer stem cells
- (2011) Fanyin Meng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNAs involved in neoplastic transformation of liver cancer stem cells
- (2011) Ren Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma
- (2010) X.-R. Yang et al. GUT
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM
- (2010) Y Wang et al. ONCOGENE
- AP-1-Dependent miR-21 Expression Contributes to Chemoresistance in Cancer Stem Cell-Like SP Cells
- (2010) Aya Misawa et al. ONCOLOGY RESEARCH
- Early cancer-related death after resection of hepatocellular carcinoma
- (2010) Masamichi Moriguchi et al. SURGERY
- Identification of local and circulating cancer stem cells in human liver cancer
- (2008) Zhen Fan Yang et al. HEPATOLOGY
- Liver stem cells and hepatocellular carcinoma
- (2008) Lopa Mishra et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started